Tyler Zeronda
Director of Finance/CFO at VYNE THERAPEUTICS INC.
Net worth: 325 405 $ as of 29/04/2024
Tyler Zeronda active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VYNE THERAPEUTICS INC. | Director of Finance/CFO | 17/06/2021 | - |
| Treasurer | 17/06/2021 | - |
Career history of Tyler Zeronda
Former positions of Tyler Zeronda
| Companies | Position | Start | End |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | - | - |
Training of Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Tyler Zeronda
- Experience
